ArticleSurgery today2026
The benefit of robotic gastrectomy in minimally invasive surgery for elderly patients: a propensity score-matched analysis.
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Robotic versus laparoscopic surgery in older adults: a systematic review and meta-analysis of recovery-centered outcomes.Journal of robotic surgery · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposesRobotic gastrectomy (RG) offers superior dexterity and visualization compared with laparoscopic gastrectomy (LG). However, its high cost requires careful patient selection. This study aimed to evaluate whether these advantages provide clinical benefits for elderly patients who are vulnerable to surgical stress.
methodsThis retrospective study included 656 patients with gastric or esophagogastric junction cancer who underwent R0 RG or LG. The patients were stratified into elderly (≥ 75 years, n = 300) and non-elderly (< 75 years, n = 356). Propensity score matching was performed within each group to adjust baseline differences, and the outcomes were compared.
resultsIn elderly patients, RG caused fewer postoperative complications (grade ≥ III) (3.0% vs. 11.0%, P = 0.03) and lower postoperative C-reactive protein (P = 0.03) and drain amylase levels (P = 0.02). In non-elderly patients, RG led to lower drain amylase levels (P = 0.002). However, the complication rates did not differ significantly (3.8% vs. 7.6%, P = 0.29). No significant differences in the recurrence-free survival or overall survival were observed.
conclusionsRG may reduce postoperative complications in elderly patients, thus supporting a potential benefit in this population.
Indexed as
Identifiers
42301414What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.